Louis Lacombe
Chercheur universitaire clinicien
Axe Oncologie
Métastases et progression du cancer
Mécanismes de la carcinogenèse
Urologie
Oncologie clinique
Dernières nouvelles
Publications
Voir tout-
article Choueiri TK, Motzer RJ, Karam JA, Yip W, Suárez C, Ye D, He Z, Caglevic C, Ferguson T, Chang YH, Rojas C, Iacovelli R and Ürün Y, Verzoni E, Vázquez Limón JC, Porta C, Uzzo RG, Lee JL, Venugopal B, McKay RR, Hammers H, Miyake H, Chahoud J, Liu H, Burgents JE, Sharma M, Powles TB and
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma
N Engl J Med 395 (1), 2026.
-
article Moussa H, Tourigny R, Robitaille K, Bussières V, Fadel J, Ben Souilah F, Diabaté L, Hovington H, Bettan L, Lacombe L, Dujardin T, Lodde M, Toren P, Aprikian A, Saad F, Carmel M, Jeldres C, Lamarche B, Bergeron A, Fradet Y, Fradet V and
Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) – a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation t…
BMJ Open 16 (5), 2026.
-
article Soliman C, Sathianathen N, Corcoran NM, Wuethrich PY, Furrer MA and
International Multicentre Analysis of Perioperative Complications Following Major Urologic Oncologic Surgery: Early Results from More than 130 000 Procedures from the CAMUS Colla…
Eur Urol Focus 2026.
Projets
- Biobangue UR0-1, du 2025-03-01 au 2029-03-30
- Metabolomics and lipidomics of prostate cancer progression: Leveraging the PROCURE, du 2025-03-01 au 2027-03-30
- Étude sur le role de la voie des glycosyltransferase CUGT) en cancer de la vessie, du 2025-03-01 au 2030-03-30
- Non-invasive biomarkers and patient-reported outcomes for precision oncology in Prostate Cancer, du 2026-06-01 au 2029-05-31
- Caractérisation hormonale et métabolique de l'évolution du cancer de la prostate dans la cohorte IRONMAN, du 2026-04-01 au 2029-04-01
- UGT2B28 IS A PROGNOSTIC AND PREDICTIVE BIOMARKER IN PROSTATE CANCER, du 2023-09-01 au 2025-08-31
- Scale-up and validation of personalized outcome prediction model for newly diagnosed prostate cancer patients by integrating clinicopathological data and multi-task artificial , du 2024-06-17 au 2025-06-16
- Metabolomics and lipidomics of prostate cancer progression: Leveraging the PROCURE Biobank, du 2024-07-10 au 2025-03-31